Measuring Glucose Uptake with 2-NBDG
What the Probe Does and Does Not Do
2-NBDG is 2-deoxyglucose labelled with a fluorophore. Like 2-DG it is transported by glucose transporters and phosphorylated by hexokinase, and the phosphorylated form accumulates because it cannot be further metabolised.
| Property | Consequence |
|---|---|
| Transported by GLUTs | Reports transporter-mediated entry |
| Phosphorylated by hexokinase | Accumulation depends on hexokinase activity, not only transport |
| Fluorescent, not radioactive | Convenient, but with spectral and quenching considerations |
| Subject to efflux | The trapped fraction is not always complete |
| Competitive with glucose | The medium's glucose concentration changes the result |
Important distinction. The signal is a balance of entry, phosphorylation and efflux. A change in fluorescence can be produced by a change in transporter number, in hexokinase activity, in efflux, or in the medium's glucose concentration. Only the first of these is "glucose uptake" in the narrow sense.
Part 1 — Conditions That Determine the Result
| Parameter | Practical range | Why |
|---|---|---|
| Probe concentration | 10–100 µM | Above this, quenching and osmotic effects appear |
| Incubation time | 10–30 min | Longer windows allow efflux and metabolism to dominate |
| Glucose in the medium | Low or serum-free during loading | Competition; must be identical across conditions |
| Temperature | 37 °C for uptake; 4 °C as a control | 4 °C distinguishes binding from transport |
| Washing | Ice-cold buffer, consistent | Removes surface-bound probe |
| Cell density | Matched | Signal per cell depends on confluency |
The fourth row is the most informative control and the least reported. A 4 °C incubation blocks transporter cycling while leaving surface binding intact; a signal at 4 °C that is a large fraction of the 37 °C signal indicates that binding, not uptake, dominates.
Part 2 — Flow Versus Imaging
| Format | Strength | Limitation |
|---|---|---|
| Flow cytometry | Per-cell distribution; high throughput | Requires detachment, which stresses cells and can internalise probe |
| Live imaging | Spatial information; kinetics in one cell | Photobleaching; lower throughput |
| Plate reader | Convenience | No single-cell resolution; well-position artefacts |
Caveat on detachment for flow. Trypsinisation takes minutes at 37 °C, during which the probe continues to enter and to efflux. A consistent, short, cold detachment protocol is required for the comparison to hold; otherwise the processing time becomes a variable that correlates with the treatment.
Part 3 — What the Assay Can Support
| Claim | Supportable with 2-NBDG alone | Requires an additional measurement |
|---|---|---|
| "Glucose transport capacity increased" | With a 4 °C control and matched medium | Confirmation with a radioactive tracer or with glucose consumption |
| "Glucose uptake increased" | Provisionally | Glucose consumption from the medium |
| "Glycolysis increased" | No | Lactate or tracing |
| "The transporter is required" | No | Genetic or pharmacological transport perturbation |
| "Insulin sensitivity changed" | Provisionally | Dose–response; a matched translocation readout |
Readout note. 2-NBDG is not a flux measurement. A cell that takes up more glucose but metabolises it more slowly shows a higher signal with lower flux; a cell that takes up the same amount but phosphorylates faster shows a higher signal with unchanged transport. Where the claim is about flux, use medium glucose depletion alongside, or tracing.
Part 4 — Comparable Alternatives
| Method | Measures | Note |
|---|---|---|
| ³H- or ¹⁴C-2-DG | Transport plus phosphorylation | The classical standard; radioactive |
| ¹³C-glucose consumption | Net uptake into metabolism | Requires sufficient consumption for detection |
| Medium glucose depletion | Net uptake | Sensitive when the rate is high; insensitive when low |
| Glucose biosensor (genetically encoded) | Intracellular glucose | Compartment-resolved; demanding |
| 2-NBDG | Accumulation | Convenient; interpretively weakest |
The fifth row is not a criticism of the probe; it is a statement about how much weight it can carry. In a figure with three other measurements, it is a useful confirmation. As the sole evidence for "glucose uptake increased", it is thin.
Part 5 — Common Failures
- • Glucose concentration in the loading medium not reported, although it determines competition.
- • Loading time not fixed between conditions.
- • No 4 °C control, so surface binding is included in the signal.
- • Detachment time differing between treated and control samples.
- • Signal reported as flux.
- • Photobleaching uncorrected in imaging-based quantification.
- • Probe concentration above the quenching range, producing a non-linear signal.
- • Density differences that change signal per field without changing per-cell uptake.
Part 6 — Where This Article Connects
This article supports the pillar's uptake module: it is the fastest measurement and the one that needs the most corroboration. The Seahorse articles cover the acidification route and its pitfalls; the lactate assay article covers the product measurement; and the HK2 article covers the case where uptake and phosphorylation diverge.
If you need uptake measured with tracer confirmation and matched loading conditions, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
Probe kinetics, efflux and transporter specificity vary by cell type and by the transporters expressed; the ranges here are starting points.
2-NBDG accumulation is not a transport rate and not a flux; it reports the net result of entry, phosphorylation and efflux over the loading window.
Scientific interpretation and experimental design
- • Accumulation, not uptake. Three processes contribute.
- • Use a 4 °C control. It separates binding from transport.
- • Fix the loading window. Efflux accumulates with time.
- • Report medium glucose. It sets competition.
- • Match detachment time. Processing becomes a variable.
- • Corroborate with consumption or tracing if the claim is about flux.
Selected references for further reading
- • Yamada K, Saito M, Matsuoka H, Inagaki N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nature Protocols. 2007;2:753–762.
- • Zou C, Wang Y, Shen Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. Journal of Biochemical and Biophysical Methods. 2005;64:207–215.
- • TeSlaa T, Teitell MA. Techniques to monitor glycolysis. Methods in Enzymology. 2014;542:91–114.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »